The new capabilities are available starting today, with some features in beta or public preview.

- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Nirogacestat significantly improved progression-free survival and objective response rates in desmoid tumor patients compared ...

Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term results will be key.

Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...

Valentin George Cretu demonstrates how integrated planning enabled Mozambique LNG and created thousands of global jobs ...

PRESSADVANTAGE – StephenTwomey.com has released a new educational resource titled “The Ultimate Glossary of Hedge Fund, Private Equity & Alternative Investment Terms (2025 Guide)”, offering accredited ...

Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...

Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed Patients ...

An international research consortium co-led by scientists from Vanderbilt University Medical Center, the University of Toronto and University of Pittsburgh has mapped the functional impact of more ...

We often encounter patients taking multiple medications, which complicates choosing safe and effective antimicrobial ...

Greene Tweed examines failure behavior, identifying key factors for improvement and demonstrating sufficient design for ...